ARTICLE | Company News
Pepscan Holding, Zealand Pharma inflammation, gastrointestinal news
March 28, 2011 7:00 AM UTC
Zealand and Pepscan's Pepscan Therapeutics B.V. subsidiary will collaborate over the next two years to identify a lead dual acting peptide candidate to enter preclinical development for chronic infla...